Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-011771
Filing Date
2025-01-24
Accepted
2025-01-24 06:04:50
Documents
6
Period of Report
2025-01-24

Document Format Files

Seq Description Document Type Size
1 6-K d910110d6k.htm 6-K 9850
2 EX-99.1 d910110dex991.htm EX-99.1 17154
3 EX-99.2 d910110dex992.htm EX-99.2 19074
4 GRAPHIC g910110g0123223608277.jpg GRAPHIC 2601
5 GRAPHIC g910110g0123223947986.jpg GRAPHIC 2601
6 GRAPHIC g910110img1.jpg GRAPHIC 1294
  Complete submission text file 0001193125-25-011771.txt   56693
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25551519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)